Cancer research
Editor's Note: The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors.
Diana Spiegelberg, Anja C Mortensen, Sara Lundsten, Christopher J Brown, David P Lane, Marika Nestor
Published: 202510.1158/0008-5472.CAN-25-4015
No abstract available for this study.